Literature DB >> 31156755

Development of the Physical Activity Tracking Preference Questionnaire.

Emily Fu1,2, Marney A White1,3, Jaclyn M W Hughto4,5, Bella Steiner1, Erik A Willis6,7.   

Abstract

The present study aims to develop the Physical Activity Tracking Preference Questionnaire (PATPQ), a measure of unit (distance, steps, calories, minutes) preference for tracking physical activity. The PATPQ was developed in two phases. During Phase One, the initial PATPQ was created (24 items), was assessed by an expert panel for face validity, and tested in 557 adults. Results were used to revise and modify the PATPQ. In Phase Two, the item pool was expanded and tested in 374 adults. Kuder-Richardson Formula 20 scores for internal consistency and interclass correlations for test-retest reliability were calculated. Internal consistency for the final questionnaire was 0.78, 0.79, 0.89 and 0.69 for the distance, steps, calories, and minutes components, respectively. Test-retest reliability coefficients were within acceptable ranges (0.65-0.75). Overall, the PATPQ can be used to identify individual preferences for tracking physical activity to help personalize exercise programs.

Entities:  

Keywords:  Exercise; exercise prescription; health behavior; measurement; tracking units

Year:  2019        PMID: 31156755      PMCID: PMC6541209     

Source DB:  PubMed          Journal:  Int J Exerc Sci        ISSN: 1939-795X


  2 in total

1.  Describing Transitions in Adherence to Physical Activity Self-monitoring and Goal Attainment in an Online Behavioral Weight Loss Program: Secondary Analysis of a Randomized Controlled Trial.

Authors:  Melissa L Stansbury; Jean Harvey; Rebecca A Krukowski; Christine A Pellegrini; Xuewen Wang; Delia Smith West
Journal:  J Med Internet Res       Date:  2022-01-28       Impact factor: 5.428

2.  Development and Validation of a Knowledge, Attitudes and Practices Questionnaire on COVID-19 (KAP COVID-19).

Authors:  Da-In Park
Journal:  Int J Environ Res Public Health       Date:  2021-07-14       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.